Current Issue


AHA issues statement on coronary artery disease management in patients with diabetes

The American Heart Association (AHA) addressed use of antithrombotics, hypertension drugs, and cholesterol therapies in patients with stable coronary artery disease and diabetes, among other recommendations.

SGLT-2 inhibitors associated with fewer serious renal events than DPP-4 inhibitors

In a propensity-matched Scandinavian study, new users of sodium-glucose cotransporter-2 (SGLT-2) inhibitors had a lower risk of renal replacement therapy and hospital admission for renal events than new users of dipeptidyl peptidase-4 (DPP-4) inhibitors.

Preop metformin associated with better postop outcomes in type 2 diabetes

A retrospective cohort study used electronic health record data from one health care system to assess postoperative mortality and readmission rates in adults who had major surgery.

MKSAP quiz: Primary prevention

This month's quiz asks readers to evaluate a 69-year-old man with hypertension, atrial fibrillation, and type 2 diabetes to choose appropriate primary prevention for cardiovascular disease.

Spotlight on COVID-19 and diabetes

Experts gave advice on which diabetes drugs should be stopped in patients with COVID-19, and studies highlighted associations between the two diseases.

In screen-detected type 2 diabetes, intensive therapy did not differ from usual care for CV events at 10 years

Despite the lack of observed benefit in this analysis, primary care physicians should continue to operate under the reasonable assumption that addressing cardiovascular (CV) risk factors improves longevity, said an ACP Journal Club commentary.

Glucose meter recalled due to incorrect unit of measure

The TRUE METRIX AIR Blood Glucose Meter displayed glucose results in mmol/L rather than mg/dL.